SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
18-Nov-24 10:00 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-Nov-24 | Payment of Exercise | 613 | $7.92 | $4,854.96 | (< 1%) 68.48K to 67.87K | |
16-Aug-24 4:48 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-Aug-24 | Payment of Exercise | 613 | $7.02 | $4,303.26 | (< 1%) 69.1K to 68.48K | |
21-May-24 4:04 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 17-May-24 | Option Exercise | 10,000 | $1.04 | $10,400.00 | 17% 59.1K to 69.1K | |
16-May-24 6:56 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-May-24 | Payment of Exercise | 613 | $8.36 | $5,124.68 | (1%) 59.71K to 59.1K | |
16-Feb-24 5:08 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-Feb-24 | Payment of Exercise | 723 | $3.40 | $2,458.20 | (1%) 60.43K to 59.71K | |
16-Nov-23 7:41 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-Nov-23 | Payment of Exercise | 2,450 | $5.08 | $12,446.00 | (4%) 62.88K to 60.43K | |
06-Jun-23 4:15 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 05-Jun-23 | Option Exercise | 9,225 | $1.04 | $9,594.00 | 17% 53.66K to 62.88K | |
16-Nov-22 7:18 PM View: | Acrivon Therapeutics, Inc. (ACRV) | 14-Nov-22 | Grant | 33,383 | -- | -- | 165% 20.27K to 53.66K |